Tolerance and autoimmunity in the liver.
- Published in:
- Seminars in Immunopathology, 2022, v. 44, n. 4, p. 393, doi. 10.1007/s00281-022-00952-6
- By:
- Publication type:
- Article
Works matching IS 18632297 AND DT 2022 AND VI 44 AND IP 4
Results: 12
1
2
How genetic risk contributes to autoimmune liver disease.
- Published in:
- Seminars in Immunopathology, 2022, v. 44, n. 4, p. 397, doi. 10.1007/s00281-022-00950-8
- By:
- Publication type:
- Article
3
MAIT cells in liver inflammation and fibrosis.
- Published in:
- Seminars in Immunopathology, 2022, v. 44, n. 4, p. 429, doi. 10.1007/s00281-022-00949-1
- By:
- Publication type:
- Article
4
Harnessing the liver to induce antigen-specific immune tolerance.
- Published in:
- Seminars in Immunopathology, 2022, v. 44, n. 4, p. 475, doi. 10.1007/s00281-022-00942-8
- By:
- Publication type:
- Article
5
Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease.
- Published in:
- Seminars in Immunopathology, 2022, v. 44, n. 4, p. 461, doi. 10.1007/s00281-022-00940-w
- By:
- Publication type:
- Article
6
The intestinal and biliary microbiome in autoimmune liver disease—current evidence and concepts.
- Published in:
- Seminars in Immunopathology, 2022, v. 44, n. 4, p. 485, doi. 10.1007/s00281-022-00936-6
- By:
- Publication type:
- Article
7
B cells in autoimmune hepatitis: bystanders or central players?
- Published in:
- Seminars in Immunopathology, 2022, v. 44, n. 4, p. 411, doi. 10.1007/s00281-022-00937-5
- By:
- Publication type:
- Article
8
Bile acids and their receptors: modulators and therapeutic targets in liver inflammation.
- Published in:
- Seminars in Immunopathology, 2022, v. 44, n. 4, p. 547, doi. 10.1007/s00281-022-00935-7
- By:
- Publication type:
- Article
9
Correction to: Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
10
Th17 cells in the liver: balancing autoimmunity and pathogen defense.
- Published in:
- Seminars in Immunopathology, 2022, v. 44, n. 4, p. 509, doi. 10.1007/s00281-022-00917-9
- By:
- Publication type:
- Article
11
TNF in the liver: targeting a central player in inflammation.
- Published in:
- Seminars in Immunopathology, 2022, v. 44, n. 4, p. 445, doi. 10.1007/s00281-022-00910-2
- By:
- Publication type:
- Article
12
Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.
- Published in:
- Seminars in Immunopathology, 2022, v. 44, n. 4, p. 527, doi. 10.1007/s00281-022-00909-9
- By:
- Publication type:
- Article